Publications

Mesenchymal Stem Cells for Bronchopulmonary Dysplasia: Phase 1 Dose-Escalation Clinical Trial

PNEUMOSTEM
Date
2014-02-06 14:25
Views
75
Issue information : J Pediatr. 2014 May;164(5):966-972.e6. doi: 10.1016/j.jpeds.2013.12.011

Co-author : Yun Sil Chang, So Yoon Ahn, Hye Soo Yoo, Se In Sung, Soo Jin Choi, Won Il Oh, Won Soon Park


In phase I clinical trial, Intratracheal transplantation of PNEMOSTEM in preterm infants at high risk for bronchopulmonary dysplasia was shown to be safe and feasible.